112
Participants
Start Date
February 29, 2008
Primary Completion Date
May 31, 2012
Study Completion Date
May 31, 2012
CTLA-4 Ig
Intravenous infusion of 10 mg/kg of CTLA-4 Ig every other week for the first two doses and then every 28 days for a total of 27 doses
Placebo
Intravenous infusions of placebo every other week for the first two doses and then every 28 days for a total of 27 doses
Columbia University, Naomi Berrie Diabetes Center, New York
University of Pittsburgh, Children's Hospital of Pittsburgh, Pittsburgh
University of Miami, Miami
University of Minnesota, Minneapolis
The Barbara Davis Center for Childhood Diabetes, Aurora
Childrens Hospital Los Angeles, Los Angeles
University of California - San Francisco, San Francisco
Stanford University, Stanford
Benaroya Research Institute, Seattle
University of Florida, Gainesville
Joslin Diabetes Center, Boston
University of Texas, Southwestern Medical School, Dallas
The Hospital for Sick Children, Toronto
Collaborators (1)
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Juvenile Diabetes Research Foundation
OTHER
American Diabetes Association
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH